# A Registry-based Randomized Controlled Trial in Type 2 Diabetes With Cardiovascular Risk Factors (REMATCH)

Study · id `cardio:ct-nct06627322` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06627322](<https://clinicaltrials.gov/study/NCT06627322>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06627322

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 5950 participants.

## Technical summary

Registry record NCT06627322. Randomized; no masking; primary purpose prevention. Start 2024-11-21 (actual); primary completion 2029-09-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose prevention
- Phase: Not applicable
- Enrolled: 5950 participants (planned count; ClinicalTrials.gov record NCT06627322, source copy `cardio:ctgov-nct06627322-2025-04-24`, retrieved 2026-10-26)
- Started: 2024-11-21 (actual) (ClinicalTrials.gov record NCT06627322, source copy `cardio:ctgov-nct06627322-2025-04-24`, retrieved 2026-10-26)
- Primary completion: 2029-09-30 (anticipated) (ClinicalTrials.gov record NCT06627322, source copy `cardio:ctgov-nct06627322-2025-04-24`, retrieved 2026-10-26)
- Completion: 2029-09-30 (anticipated) (ClinicalTrials.gov record NCT06627322, source copy `cardio:ctgov-nct06627322-2025-04-24`, retrieved 2026-10-26)
- Countries: South Korea (ClinicalTrials.gov record NCT06627322, source copy `cardio:ctgov-nct06627322-2025-04-24`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06627322-2025-04-24`, retrieved 2026-10-26)

## The registry's words

- Brief title: A Registry-based Randomized Controlled Trial in Type 2 Diabetes With Cardiovascular Risk Factors (REMATCH)
- Acronym: REMATCH
- Condition: Type 2 Diabetes
- Intervention (Drug): Dual-combination therapy
- Intervention (Drug): Triple-combination therapy
- Intervention (Device): Dexcom G7, Pasta
- Lead sponsor: Kyu Chang Won
- Lead sponsor class: OTHER
- Collaborator: Boryung Pharmaceutical Co., Ltd
- Collaborator class: INDUSTRY
- Collaborator: Dong-A ST Co., Ltd.
- Collaborator class: INDUSTRY
- Collaborator: HK inno.N Corporation
- Collaborator class: INDUSTRY
- Collaborator: Daewoong Pharmaceutical Co. LTD.
- Collaborator class: INDUSTRY
- Collaborator: Chong Kun Dang Pharmaceutical Corp.
- Collaborator class: INDUSTRY
- Collaborator: Celltrion
- Collaborator class: INDUSTRY
- Collaborator: Kakao Healthcare Corp.
- Collaborator class: UNKNOWN
- Collaborator: Handok Inc.
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry condition terms include this condition: Diabetes mellitus (`core:diabetes-mellitus`)
- Registry lists this organization as a collaborator: Boryung Pharmaceutical Co., Ltd (`cardio:org-boryung-pharmaceutical-co-ltd`)
- Registry lists this organization as a collaborator: Dong-A ST Co., Ltd. (`cardio:org-dong-a-st-co-ltd`)
- Registry lists this organization as a collaborator: HK inno.N Corporation (`cardio:org-hk-inno-n-corporation`)
- Registry lists this organization as a collaborator: Daewoong Pharmaceutical Co. LTD. (`cardio:org-daewoong-pharmaceutical-co-ltd`)
- Registry lists this organization as a collaborator: Chong Kun Dang Pharmaceutical Corp. (`cardio:org-chong-kun-dang-pharmaceutical-corp`)
- Registry lists this organization as a collaborator: Celltrion (`cardio:org-celltrion`)
- Registry lists this organization as a collaborator: Handok Inc. (`cardio:org-handok-inc`)

## Provenance

Content hash: 069df49621bc98cb09f138451cc0976e8f2c14ab07051af82682cdcf92a109ff
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
